REDHAWK NAMES
DR. DREW PINSKY AS NATIONAL
SPOKESPERSON
Media
Contact:
Julie
Calzone
(337)
235-2924
jcalzone@calzone.com
Company
Contacts:
G. Darcy
Klug, Chairman,
CEO and
CFO
(337)
269-5933
darcy.klug@redhawkholdingscorp.com
Lafayette,
LA -- July 25, 2019 -- InvestorsHub NewsWire
-- RedHawk
Holdings Corp. (OTC:
IDNG) (the "Company"
or
"RedHawk"), announced today
that Dr. Drew
Pinsky (commonly known as
"Dr. Drew")
has agreed to
become the Company's
exclusive
spokesperson for its Sharps and Needle
Destruction Device ("SANDD")
mini™ and its SANDD
Pro™ needle
incineration devices (collectively the
"SANDD™
Products") and any related products and/or
accessories.
Dr. Drew is a
private practice physician, an internist, addiction medicine
specialist and media personality. He has an undergraduate degree
in biology from Amherst College and earned his Doctor of Medicine
degree from the University of Southern California School of
Medicine. He served his residency in internal medicine at USC
County Hospital and became chief resident at Huntington Memorial
Hospital in Pasadena, California before moving into private
practice.
The
SANDD
mini™
(formerly known as
The Disintegrator™) is a portable, lithium-ion battery operated, needle
destruction device primarily for use by self-injector
diabetics
in the
home.
In clinical
settings, the SANDD
mini™
can be used
by allergist,
dermatologist, cosmetologist, plastic surgeons and other medical
specialists without the need for sharps
containers for needle disposal. The SANDD
mini™
provides
diabetics
with
the safe and
environmentally friendly disposal of needles following their
use in a
home setting and is an effective alternative
to hazardous waste needle disposal utilizing sharps
containers. The SANDD
mini™ is the only FDA-approved portable,
battery-operated needle destruction device that
eliminates the use of sharps containers for disposal in both
clinical and home settings.
The
SANDD
Pro™ is
capable of incinerating hypodermic
needles 18-gauge and higher, up to 8 inch
in length. Additionally, SANDD
Pro™ technology is expected to
feature a portable,
rechargeable, lithium-ion battery operated unit. RedHawk
believes that this portable unit (the
"SANDD
Pro™ - Portable") will incinerate as many as 300 needles, ranging
in gauges as thick as 21 gauge and lengths up to 8" on a single charge.
RedHawk expects that the SANDD
Pro™ - Portable will be ideal for field use by first
responders, home health care nurses, veterinarians and home use
injectors. The SANDD
Pro™ is both FDA approved and OSHA
compliant.
The complete line
of SANDD™
products is
expected to be available for
virtually all home
and commercial applications including hospitals, first responders,
a full range of clinics and primary care physicians, dentists,
veterinarians, retirement and non-acute healthcare
facilities. The SANDD
mini™ is
currently being sold to the general public and to various Independent School
Districts in
the State of Texas. The Company has stated that it
expects to
begin offering
the SANDD
mini™ to various Independent School Districts in the State of
California before the end of 2019.
The
Company also intends to immediately begin
to develop
and initiate a social media marketing
campaign
of the sale of
the SANDD
mini™ to the
general public.
# #
#
About RedHawk Holdings Corp.
RedHawk
Holdings Corp., formerly Independence Energy Corp., is a
diversified holding company which, through its subsidiaries, is
engaged in sales and distribution of medical devices, sales
of branded
generic pharmaceutical drugs,
commercial real estate investment
and leasing,
sales of point of entry full-body security systems,
and
specialized financial services. Through
its medical
products
business unit, the Company sells the
Sharps and
Needle Destruction Device (SANDD™), WoundClot
Surgical -
Advanced Bleeding Control, and
the Carotid
Artery Digital
Non-Contact
Thermometer. Through our
United Kingdom based subsidiary, we manufacture and market branded
generic pharmaceuticals. RedHawk Energy holds the exclusive U.S.
manufacturing and distribution rights for the Centri Controlled
Entry System, a unique, closed cabinet, nominal dose transmission
full-body x-ray scanner
Cautionary Statement Regarding Forward-Looking Statements
This release
may contain forward-looking statements. Forward-looking statements
are all statements other than statements of historical fact.
Statements contained in this release that are not historical facts
may be deemed to be forward-looking statements. The words
"anticipate," "may," "can," "plans," "believes," "estimates,"
"expects," "projects," "targets," "intends," "likely," "will,"
"should," "to be," "potential" and any similar expressions are
intended to identify those assertions as forward-looking
statements.
Investors
are cautioned that forward-looking statements are inherently
uncertain. Actual performance and results may differ materially
from that projected or suggested herein due to certain risks and
uncertainties. In
evaluating forward-looking statements, you should consider the
various factors which may cause actual results to differ materially
from any forward-looking statements including those listed in the
"Risk Factors" section of our latest 10-K report. Further, the
Company may make changes to its business plans that could or will
affect its results. Investors are cautioned that the Company will
undertake no obligation to update any forward-looking
statements.
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Aug 2024 to Sep 2024
RedHawk (CE) (USOTC:SNDD)
Historical Stock Chart
From Sep 2023 to Sep 2024